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Abstract
Blood vessels form either when dispersed endothelial cells (the cells lining the inner walls of fully formed blood vessels)
organize into a vessel network (vasculogenesis), or by sprouting or splitting of existing blood vessels (angiogenesis).
Although they are closely related biologically, no current model explains both phenomena with a single biophysical
mechanism. Most computational models describe sprouting at the level of the blood vessel, ignoring how cell behavior
drives branch splitting during sprouting. We present a cell-based, Glazier–Graner–Hogeweg model (also called Cellular Potts
Model) simulation of the initial patterning before the vascular cords form lumens, based on plausible behaviors of
endothelial cells. The endothelial cells secrete a chemoattractant, which attracts other endothelial cells. As in the classic
Keller–Segel model, chemotaxis by itself causes cells to aggregate into isolated clusters. However, including experimentally
observed VE-cadherin–mediated contact inhibition of chemotaxis in the simulation causes randomly distributed cells to
organize into networks and cell aggregates to sprout, reproducing aspects of both de novo and sprouting blood-vessel
growth. We discuss two branching instabilities responsible for our results. Cells at the surfaces of cell clusters attempting to
migrate to the centers of the clusters produce a buckling instability. In a model variant that eliminates the surface–normal
force, a dissipative mechanism drives sprouting, with the secreted chemical acting both as a chemoattractant and as an
inhibitor of pseudopod extension. Both mechanisms would also apply if force transmission through the extracellular matrix
rather than chemical signaling mediated cell–cell interactions. The branching instabilities responsible for our results, which
result from contact inhibition of chemotaxis, are both generic developmental mechanisms and interesting examples of
unusual patterning instabilities.
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Introduction
Blood-vessel development is essential for myriad biological
phenomena in healthy and diseased individuals, including wound
healing and tumor growth [1,2]. Blood vessels form either de
novo, via vasculogenesis or by sprouting or splitting of existing blood
vessels via angiogenesis.
In vasculogenesis, dispersed endothelial cells (ECs; the cells lining
the inner walls of fully-formed blood vessels) organize into a
primary vascular plexus of solid cords which then remodel into a
vascular network. ECs elongate parallel to the cords, with final
aspect ratios of tens to one. Because the early stages of
vasculogenesis depend on a single cell type, vasculogenesis is
relatively easy to reproduce in vitro. When cultured in vitro on
Matrigel, a commercial product mimicking the extracellular matrix
(ECM; the mixture of proteins, growth-factors and carbohydrates
surrounding cells in vivo), even in the absence of other cell types or
positional cues, ECs organize into cords which form large-scale,
honey-comb like patterns, with cords of ECs surrounding regions
devoid of ECs. This network slowly reorganizes, with the size of
the polygonal, cell-free lacunae, gradually increasing. This obser-
vation suggests that ECs have autonomous patterning ability, rather
than following morphogen pre-patterns.
The sprouting or splitting of existing blood vessels during
angiogenesis is more complex. In the first step of angiogenesis, a
vessel dilates and releases plasma proteins that induce a series of
changes in EC behavior. The ECs which will form the sprout next
detach from each other and from the surrounding smooth-muscle
cells, destabilizing the vessel. These detached ECs proliferate,
migrate out of the vessel and organize into a sprout. EC
proliferation continues in the sprout and is fastest just behind
the leading tip cell, which is selected using a lateral-inhibition
mechanism mediated by Dll4 and Notch1 [3]. Finally, the sprout
forms a lumen, secretes a basal lamina and associates with
pericytes that stabilize the sprout to form a mature new vessel [4].
Two fundamental questions concerning vasculogenesis and
angiogenesis and their relation to each other are: 1) Does blood-
vessel formation require external patterning cues (pre-patterns of
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morphogens) to define the precise position of the ECs, or can ECs
organize into vascular patterns autonomously, with external cues
merely initiating and fine-tuning vascular morphogenesis? 2) Do
vasculogenesis and angiogenesis require the same or different cell
behaviors, molecular signals and biomechanics?
Experimental Background
Despite the biomedical importance of angiogenesis and
vasculogenesis, existing experiments are sufficiently ambiguous
that even the fundamental mechanisms guiding patterning are
uncertain. Experiments suggest a central role for chemotaxis in
both de novo and sprouting blood-vessel growth [4–6]. ECs
respond to, and often produce, a wide range of chemoattractants
and chemorepellants, including the many isoforms of vascular-
endothelial growth factor A (VEGF-A) [6], the chemokine SDF-1
[7,8], which ECs secrete [7], fibroblast growth factor 2 (FGF-2),
which induces ECs in developing vessels to secrete VEGF [9], Slit-
2, which can act either as a chemoattractant or a chemorepellant
depending on the receptor to which it binds [10], and the
chemorepelling semaphorins [10].
Which of these molecules (if any) govern vascular patterning is
still unclear. The Torino Group (e.g., [11,12]) argued that a
VEGF-A was the short-range autocrine chemoattractant that their
chemotaxis-based blood-vessel-growth model required, since ECs
express receptors for VEGF (VEGFR-2), chemotax towards sources
of VEGF under favorable conditions, and secrete VEGFs.
However, experiments suggest that cell-autonomous secretion of
VEGF is essential only for vascular maintenance, not for
angiogenesis per se: mice genetically-engineered to lack the VEGF
gene only in their ECs have normal vascular density and
patterning, but impaired vascular homeostasis and EC survival
[13]. A plausible, alternative cell-autonomous chemoattractant to
guide EC aggregation is the chemokine SDF-1/CXCL12, which
ECs both secrete and respond to [8].
However, based on experiments that suggest that ECs can
follow stresses in the ECM (see, e.g., [14] for review), Manoussaki
and Murray [15], and Namy et al. [16] proposed that mechanical
interactions rather than, or in addition to, chemical interactions
govern vasculogenesis. Further complicating this picture, Szabo
and coworkers [17] showed that non-vascular, glia or muscle cells
cultured on rigid, plastic culture dishes in continuously-shaken
medium can form linear structures. Such culture conditions should
reduce both the formation of chemoattractant gradients or
migration along stress lines in the ECM. In the absence of
ECM, they hypothesized that cells preferentially move towards
elongated structures. Szabo and coworkers [17] proposed two
mechanisms for such cell behavior: cells would align to
surrounding cells, or they would mechanotactically follow stress
fields in the cytoskeleton of neighboring cells. The molecular
mechanisms of such cell behavior remains unclear as is the
relevance of these results to ECs.
Angiogenesis and vasculogenesis also require a number of local,
contact-dependent (juxtracrine) signals: Tip-cell selection during
angiogenic sprouting depends on Delta-notch signaling [3], while
Eph receptor-ephrin ligand binding amplifies ECs’ response to
SDF-1 [8]. All ECs express vascular-endothelial-cadherin (VE-
cadherin), a homophilic, trans-membrane cell-adhesion molecule,
which appears to play a crucial role in vascular patterning [18,19].
Besides its role in cell-cell adhesion, VE-cadherin has a signaling
function that determines how ECs respond to VEGF-A. When
ECs bind to other ECs through their VE-cadherin, VEGF-A
reduces their motility and proliferation. In the absence of VE-
cadherin binding, VEGF-A activates pathways related to actin
polymerization and the cell cycle, enhancing cell motility and
proliferation in sub-confluent monolayers, and causes preferential
extension of pseudopods in directions with higher VEGF-A
concentrations [20]. We hypothesize that VE-cadherin-binding
acts locally to prevent extension of pseudopods in the direction of
cell-cell contacts for all critical chemoattractants, not only to
VEGF-A. VE-cadherin 2/2 double-knock-out mice develop
abnormal vascular networks in the yolk sac [18], with ECs forming
isolated vascular islands instead of wild-type polygonal vascular
networks. These mice also have defective angiogenic sprouting,
suggesting that both vasculogenesis and angiogenesis require VE-
cadherin. VE cadherin 2/2 ECs still form strong adhesive
junctions, so loss of VE-cadherin-mediated signaling rather than
loss of intercellular adhesion seems to be responsible for the knock-
out phenotype [18].
Computational Background
A number of models and simulations replicate features of in
vitro vascular patterning and can help partially reconstruct
minimal sets of behaviors ECs require to self-organize into
polygonal, vascular patterns [11,12,15–17,21–23]. Because of the
experiments we discussed above, and others which have
demonstrated that sprouting angiogenesis and vasculogenesis both
require chemotaxis (see, e.g., [7,8,24]), most models of vasculo-
genesis assume that intercellular signaling occurs via a diffusible
chemoattractant. Using continuum models deriving from the fluid-
dynamic Burgers’ equation, Preziosi and coworkers (called the
Torino Group in this paper) showed that simulated ECs secreting a
chemoattractant that attracts surrounding ECs, could self-organize
into polygonal patterns similar to the patterns in EC cultures and
in vivo [11,12,25,26]. However, their work assumed that
endothelial cells accelerate in chemical gradients, which is not
plausible in the highly viscous, non-inertial environment of the
ECM. Microfluidic evidence indicates that mammalian cells
(HL60) rapidly reach a flow-dependent, constant velocity [27] in
chemoattractant gradients rather than continuously accelerating.
We have previously suggested that [22] a linear force-velocity
relation is the most appropriate model of ECs’ experimental
Author Summary
A better understanding of the mechanisms by which
endothelial cells (the cells lining the inner walls of blood
vessels) organize into blood vessels is crucial if we need to
enhance or suppress blood vessel growth under patho-
logical conditions, including diabetes, wound healing, and
tumor growth. During embryonic development, endothe-
lial cells initially self-organize into a network of solid cords
via blood vessel growth. The vascular network expands by
splitting of existing blood vessels and by sprouting. Using
computer simulations, we have captured a small set of
biologically plausible cell behaviors that can reproduce the
initial self-organization of endothelial cells, the sprouting
of existing vessels, and the immediately subsequent
remodeling of the resulting networks. In this model,
endothelial cells both secrete diffusible chemoattractants
and move up gradients of those chemicals by extending
and retracting small pseudopods. By itself, this behavior
causes simulated cells to accumulate to aggregate into
large, round clusters. We propose that endothelial cells
stop extending pseudopods along a given section of cell
membrane as soon as the membrane touches the
membrane of another endothelial cell (contact inhibition).
Adding such contact-inhibition to our simulations allows
vascular cords to form sprouts under a wide range of
conditions.
Contact Inhibition in Blood-Vessel Growth
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response, with the velocity of ECs proportional to the strength of
the gradient of the chemoattractant. However, in simulations of
this simple model, isotropic ECs form well-separated rounded
clusters instead of networks. We have shown that adding one of a
number of mechanisms (including cell adhesion [21] and cell
elongation [22]) to chemotactic aggregation suffices to produce
quasi-polygonal networks. Section ‘‘Results’’ discusses these
mechanisms in more detail.
In the mechanical models of Manoussaki and Murray [15], and
Namy et al. [16] ECs pull on the elastic ECM and aggregate by
haptotactically migrating along the resulting ECM stress lines.
Surprisingly, the mathematical form of the chemical and
mechanical models is practically identical. Because these mechan-
ical models assume that ECs exert radially-symmetric stresses on
the ECM, modeling stress fields and EC haptotaxis or EC
secretion and response to a chemoattractant, results in the same
cell movement. Since simulations of the two mechanisms are
identical, distinguishing between the effects of chemical and
mechanical mechanisms will require additional experiments (such
experiments are currently underway in the Glazier laboratory
(Shirinifard, Alileche and Glazier, preprint, 2008)).
A separate set of simulations addresses angiogenesis. Many
models of sprouting blood-vessel growth introduce blood-vessel-
level phenomenology by hand through high-level rules for
branching [28–30]. Attempts to derive blood-vessel sprouting
and splitting from the underlying behavior of ECs include Levine
and coworkers’ [31] model of the onset of angiogenic sprouting as
a reinforced random walk, where the ECs degrade the ECM,
which locally enhances EC motility and produces paths of
degraded ECM, and Bauer and Jiang’s [32] cell-based model of
blood-vessel sprouting along externally generated morphogen
gradients, which assumed that branch splitting results from ECM
inhomogeneities. Neither model can explain both EC assembly
and blood-vessel sprouting.
Could the behavior of the individual ECs also explain aspects of
blood-vessel sprouting? Because the same genetic machinery
regulates both angiogenesis and vasculogenesis [4], a common
set of mechanisms is plausible. Manoussaki [33] extended her
mechanical model of vasculogenesis to describe angiogenesis by
adding long-range, chemotactic guidance cues. In her simulations,
ECs migrated from an aggregate towards a chemoattractant
source and cell-traction-driven migration contracted the sprout
into a narrow, vessel-like cord.
In this paper we present an alternative chemotaxis-based
mechanism that can produce networks both from dispersed ECs
and EC clusters without requiring long-range guidance cues.
Instead, in our model long-range signals would only steer the self-
organized vessels, a more biologically-realistic mechanism. Ex-
tending simulations that we have briefly introduced elsewhere
[23], we show that VE-cadherin-mediated contact inhibition of
chemotactic pseudopod projections, in combination with secretion
of a diffusing, rapidly decaying chemoattractant by ECs, suffices to
reproduce aspects of both de novo and sprouting blood-vessel
growth. In our simulations ECs: a) secrete a chemoattractant and
b) preferentially extend pseudopods up gradients of the chemoat-
tractant, unless, c) contact inhibition locally prevents chemotactic
pseudopod extension. Thus, cell-cell binding suppresses the
extension of chemotactic pseudopods, while unbound cell surfaces
in contact with the ECM continue to extend pseudopods towards
sources of chemoattractant [24]. We compare two biologically-
plausible scenarios for chemotaxis, one in which ECs actively
extend and retract pseudopods along chemoattractant gradients,
and one in which the pseudopods’ retractions are chemotactically
neutral. The second scenario suggests a sprouting mechanism
where a secreted autocrine factor acts both as a long-range
chemoattractant and a local inhibitor of pseudopod sprouting.
Results
We modeled endothelial cell behavior at a mesoscopic level
using the Glazier-Graner-Hogeweg (GGH) model, also known as
the Cellular Potts Model (CPM) [34–37]. The GGH is a lattice-
based Monte-Carlo approach that describes biological cells as
spatially extended patches of identical lattice indices. Intercellular
junctions and cell junctions to the ECM determine adhesive (or
binding) energies. The GGH algorithm, which we describe in
more detail in the section Materials and Methods, models
pseudopod protrusions by iteratively displacing cell interfaces,
with a preference for displacements which reduce the local effective
energy of the configuration. Cells reorganize to favor stronger rather
than weaker cell-cell and cell-ECM bonds and shorter rather than
longer cell boundaries. In addition to interface displacements that
reduce the effective energy, active cell motility also allows
displacements that increase the effective energy. The likelihood
of these active displacements increases with the cell-motility
parameter T. Further constraints regulate cell volumes, surface
areas, and chemotaxis. To model chemotaxis, we use the Savill
and Hogeweg [36] algorithm that favors extensions and retractions
of pseudopods up concentration gradients of a chemoattractant
(see Eq. 3 in the section Materials and Methods). In the simplest
implementation of chemotaxis in the GGH, cell velocity is
proportional to the strength of the chemical gradient, in general
agreement with experiments; see, e.g., [22] (we discuss the details
of chemotaxis implementation below in the subsections Sensitivity
analysis and A dissipative sprouting mechanism and in Materials
and Methods; see especially Eq. 3).
The advantage of the GGH over alternative cell-based
modeling approaches [38] that represent cells as point particles
or fixed-sized spheres or ellipsoids is that we can differentiate
between bound and unbound regions of cell membrane. The
GGH naturally represents the stochastic, exploratory behavior of
migrating cells, modeling it as the biased extension and retraction
of pseudopods, instead of a biologically-implausible single force
acting on cells’ centers of mass as in some cell-based simulations.
We described chemoattractant diffusion and degradation
macroscopically, using a continuum approximation. In analogy
to the Torino Group’s continuum model of de novo blood-vessel
growth [12,25], ECs secrete a diffusing chemoattractant at a rate
a, which degrades in the ECM at a rate e (e.g., due to proteolytic
enzymes or by binding to ECM components), obeying:
Lc
Lt
~a 1{d s ~xð Þ,0ð Þð Þ{ed s ~xð Þ,0ð ÞczD+2c, ð1Þ
where d s ~xð Þ,0ð Þ~0 inside cells and is d s ~xð Þ,0ð Þ~1 in the ECM.
Because we wish to compare our simulations to experimental yolk-
sac cultures, where the vascular patterns are essentially monolay-
ers, we use a two-dimensional GGH.
We set the chemoattractant’s secretion rate by cells
a= 1023 s21, its decay rate e= a, and its diffusion constant in
ECM to a slow D= 10213 m2 s21. These parameter values
produce steeper gradients than those for VEGF-A165, the
chemoattractant which Gamba et al. suggested was responsible
for vasculogenesis, which has a diffusion coefficient of
D,10211 m2 s21 [12]. The diffusion coefficient of SDF-1/
CXCL12 is in the range of 1.7610213 m2 s21 [39]. However,
the phenomena we observe in our simulations hold over a large
range of diffusion coefficients.
Contact Inhibition in Blood-Vessel Growth
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EC Aggregation and Vasculogenesis in the Absence of
Contact Inhibition
In in vitro cultures of mouse allantois explants, ECs (fluores-
cently labeled in red) organized into polygonal patterns
(Figure 1A–1C). When we blocked VE-cadherin receptors with
anti-VE-cadherin antibodies, thus preventing VE-cadherin recep-
tors from binding to those on apposing cells, the mouse ECs
formed isolated vascular islands (Figure 1D–1F). We hypothesize
that anti-VE-cadherin’s antibody blockage of VE-cadherin
signaling prevents contact inhibition of chemotactic motility,
sensitizing the endothelial cells to the chemoattractant at cell–cell
interfaces.
In our corresponding simulations (Figure 2A–2C and Video S1),
we randomly distributed 1,000 ECs, each with an area of
,200 mm2 over an area of <700 mm6700 mm (3336333 lattice
sites, or pixels, of 2 mm62 mm each), which we positioned inside a
larger lattice of 1,00 mm61,00 mm to minimize boundary effects.
In this cell-based simulation of the Torino Group’s continuum
model [11,12], without endothelial-cell acceleration in chemoat-
tractant gradients our cells form disconnected, vascular islands
rather than a vascular network. We would expect this result,
because with the more realistic chemotactic response we employ,
the Torino Group’s model reduces to the classic Keller-Segel
equations [40] of chemotactic aggregation [25], which, like our
simulations, form isolated vascular islands. Apparently, the basic
Torino-Group model of chemotactic cell aggregation misses a
biological mechanism essential for vasculogenesis. We have
previously suggested a number of additional mechanisms, any
one of which, together with cell aggregation, suffices to induce
vasculogenesis-like patterning. For example, when we gave the
ECs the elongated shapes observed in later stages of experiments,
neighboring cells aligned with each other, causing cell clusters to
elongate and interconnect, creating a vascular network, in a
mechanism similar to Szabo’s [17]. These vascular networks
remodel gradually, with dynamics resembling those of in vitro
vascular networks. The causes of cell elongation in experiments
are not clear. ECs could elongate either cell-autonomously (e.g., by
remodeling their cytoskeletons), or non-cell-autonomously, by
Figure 1. Anti-VE-cadherin antibody treatment inhibits de novo blood-vessel growth in mouse allantois cultures. Endothelial cells
fluorescently labeled in red with endothelium-specific CD34-Cy3 antibody. DIC/fluorescent image overlays. (A–C) Control. (D–F) Anti-VE-cadherin-
treated cell cultures.
doi:10.1371/journal.pcbi.1000163.g001
Figure 2. Endothelial cell aggregation; simulation initiated
with 1000 scattered cells. (A) After 10 Monte Carlo steps (MCS)
(,5 min). (B) After 1000 MCS (,8 h). (C) After 10,000 MCS (,80 h). (D)
Contact-inhibited chemotaxis drives formation of vascular networks.
Scale bar: 50 lattice sites (<100 mm). Contour levels (green) indicate ten
chemoattractant levels relative to the maximum concentration in the
simulation. Grey shading indicates absolute concentration on a
saturating scale.
doi:10.1371/journal.pcbi.1000163.g002
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maximizing their contact areas with surrounding cells or by
aligning to morphogen gradients in the ECM [22]. Unless we state
otherwise, in this paper we neglect cell-autonomous elongation.
Even without strong cell-cell adhesion the ECs can form
vascular-like structures in simulations of vasculogenesis if the
diffusion length of the chemoattractant (the length L over which the
concentration drops to half its value at the EC membrane) is short
enough, because the ECs align with the chemical gradients [23].
This length scale L depends on the diffusion coefficient D and the
chemoattractant decay rate e as L~
ffiffiffi
D
e
q
[12].
Sprouting Angiogenesis in the Absence of Contact-
Inhibition
To investigate whether the Torino-Group Model could reproduce
sprouting angiogenesis, we started our simulations with rounded
clusters of simulated ECs representing a blood vessel’s surface after
degradation of the ECM, keeping the simulation parameters
unchanged from Figure 2. As in vasculogenesis, cell-elongation
sufficed to drive angiogenesis-like sprouting (see Figure 3A–3C),
where we used a length constraint, see [22]). EC clusters also
produced sprouts for strong cell-cell adhesion (i.e., for values of
J(c,c),10); Figure 3D–3F), via a mechanism similar to the cell-
elongation-dependent mechanism for vasculogenesis [22]. Adhesion-
independent sprouting occurred only for a narrow range of very small
diffusion constants of the chemoattractant, between
D,2?10214 m2 s21 and D.2?10214 m2 s2 (see Figure 3G–3I).
The allowable range of D increased for bigger cells [23]. We also
systematically screened for sprouting in the absence of contact-
inhibited chemotaxis. We present the results of these screens in the
section Sensitivity analysis and in Figure S1, but we defer an in-depth
study of these phenomena to our future work.
Contact-Inhibited Chemotaxis in De Novo Blood Vessel
Growth
In this paper, we focus on the role of contact-inhibited
chemotaxis in sprouting blood-vessel growth. We hypothesize that
VE-cadherin’s local inhibition of chemotaxis-induced pseudopod
extensions at EC-EC boundaries, may be responsible for ECs’ self-
organization into vascular-like networks.
We modeled contact inhibition of chemotaxis in our simulations
by suppressing chemotaxis at cell-cell interfaces. Thus, only
interfaces between cells and ECM respond to the chemoattractant.
Figure 2D and Video S2 and Video S3 show typical simulations of
de novo blood-vessel growth with contact inhibition. The ECs
assemble into a structure resembling a capillary plexus: cords of
cells enclose lacunae, which grow slowly. Smaller lacunae shrink
and disappear, while larger lacunae subdivide via vessel sprouting
as, for example, in the quail yolk sac [41].
Contact-Inhibited Chemotaxis in Blood Vessel Sprouting
To investigate the role of contact-inhibited chemotaxis in blood
vessel sprouting, we ran a set of simulations with a large cluster of
endothelial cells representing a blood vessel’s surface after
degradation of the ECM, keeping all simulation parameters the
same as those in Figure 2D. The surface of the cluster first roughens,
with some cells protruding from the surface, then digitates into a
structure reminiscent of a primary vascular plexus (Figure 4A–4C
and Video S4 and Video S5), the first type of structure to develop in
both de novo and sprouting blood-vessel growth [41]. The sprouting
instability requires contact inhibition of chemotaxis. Without it, the
clusters remained rounded and compact (Figure 4D). Thus our
simulations suggest that a process operating at the level of individual
cells—chemotaxis with contact inhibition—may drive in vitro
blood-vessel growth both sprouting and de novo.
What drives blood vessel sprouting in our model? At
equilibrium, the chemoattractant has a quasi-Gaussian profile
across the cluster. It levels off towards the cluster’s center, while its
inflection point is at the cluster boundary. Chemotaxis produces a
continuous, inward, normal force at the cluster boundary, creating
a buckling instability (see, e.g., [42]); chemotactic forces also
compress small initial bumps laterally, producing sprouts. Since
contact inhibition of chemotaxis leaves the interior cells insensitive
to the chemoattractant, ingressing surface cells easily push them
aside. When we omit contact inhibition of motility to mimic anti-
VE-cadherin-antibody-treated allantois cultures, the interior cells
also feel the inward-directed chemotactic forces and resist
displacement (Figure 4D and Video S6).
To explore this idea, we varied the ratio of the chemotactic
response at cell–cell interfaces relative to the chemotactic response
at cell-ECM interfaces (x(c,c)/x(c,M)), where x(c,c)is the ECs’
sensitivity to the chemoattractant at cell-cell interfaces and x(c,M)
the sensitivity at cell-ECM interfaces (see the section Materials and
Methods for details). We looked for sprouting in clusters of
128 cells, each of area ,200 mm2, placed in a 400 mm6400 mm
lattice, keeping all other parameters unchanged from their values
in Figure 4.
We defined the clusters’ compactness after 10,000 Monte Carlo
Steps (the time unit of the simulation, see the section Materials and
Methods, with 1 MCS equivalent to about 30 s) to be C=Acluster/
Ahull, the ratio between the cluster’s area, Acluster, and the area of its
convex hull (that is the tightest possible ‘‘gift wrapping’’ around the
cluster), Ahull. The compactness C= 1 for a perfectly circular cluster,
whereas CR 0 for highly branched or dispersed clusters of cells.
Figure 3. Sprout formation in the absence of contact inhibition.
(A–C) Cell-autonomous cell elongation; (A) L=22 mm; (B) L= 24 mm;
(C) L= 32 mm; (D–F) Adhesion-driven sprouting. (D) J(c,c) = 1; (E)
J(c,c) = 5; (F) J(c,c) = 10; (G–I) Passive cell elongation at short diffusion
lengths; (G) D = 1?10214 m2 s21; (H) D = 2?10214 m2 s21; (I)
D= 3?10214 m2 s21.
doi:10.1371/journal.pcbi.1000163.g003
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We found a phase transition at (x(c,c)/x(c,M))<0.5 separating
sprouting from non-sprouting clusters (Figure 5), suggesting that
the sprouting instability only occurs when the core of the cluster
behaves as a fluid: because each cell’s volume is nearly conserved
(apart from small fluctuations around its target volume), the core
cells can only release the pressure the ingressing cells exert on
them by moving outwards as sprouts. Our ongoing work
characterizes this instability mathematically, proving that the
cluster self-organizes into a network structure with fixed cord
width (A. Shirinifard and J. A. Glazier, preprint 2008).
To validate our model against published EC tracking
experiments [19], we compared the trajectories of cells in
sprouting and non-sprouting clusters. Figure 6A–6D shows the
trajectories of ten cells in a sprouting cluster (with contact-
inhibition; Figure 6A–6B), and ten cells in a non-sprouting cluster
(without contact-inhibition; Figure 6C–6D). In non-sprouting
clusters, cells followed random-walk trajectories, while in sprouting
clusters, they followed biased random-walk trajectories. To further
characterize cell motility, we measured cells’ average displace-
ments and velocities over 10 independent simulations of 128 cells
each. In sprouting clusters, the cells moved further during a given
interval than in non-sprouting clusters. Thus, the cell velocity
Vi tð Þ~ ~xi tzDtð Þ{~xi t{Dtð Þð Þ=2Dt [19] is larger during sprout-
ing if the interval Dt between subsequent cell positions is
sufficiently large (here we use Dt= 2.5 h as in Perryn et al. [19]);
for shorter intervals (e.g., 30 s) the cell velocity is highest in non-
sprouting clusters (not shown), indicating that ECs in sprouting
clusters moved faster, but had a somewhat slower random motility.
Our simulations agree with recent experiments tracking ECs in
embryonic mouse allantoides [19] that measured the cell-
autonomous motility of ECs cells in allantoides relative to the
motility of the surrounding mesothelium in which the ECs reside.
Administration of anti-VE-cadherin antibodies reduced both cell-
autonomous motion and net displacement of ECs. Thus, our
simulations suggest that VE-cadherin’s role as a contact-dependent
inhibitor of cell motility suffices to explain the reduced cell motility
observed in anti-VE-cadherin-treated allantoides cultures.
Sensitivity Analysis
Contact-inhibited sprouting occurs for a wide range of
parameter values. In most of our simulations we set the EC-EC
adhesion equal to the EC-ECM adhesion (i.e., J(c,c) = 2J(c,M); the
factor of 2 arises because we model the ECM as a single large
generalized cell), which is equivalent to setting the surface tension
of the cluster to zero [35]. Zero surface tension clarifies the role of
contact inhibition in sprouting, but real ECs adhere strongly to
each other via adherens junctions [18]. In Figure 7 and in Video S7,
S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20,
S21, S22, we studied the effect of cell-cell adhesion on sprouting in
Figure 4. Sprouting instability in a simulation initiated with a cluster of endothelial cells. (A) After 10 MCS (5 min). (B) After 1,000 MCS
(,8 h). (C) After 10,000 MCS (,80 h). (D) No sprouting in a simulation without contact inhibition of chemotaxis (x(c,c)/x(c,M) = 1) at 10,000 MCS
(,80 h). Scale bar: 50 lattice sites (<100 mm).
doi:10.1371/journal.pcbi.1000163.g004
Figure 5. Compactness (C=Acluster/Ahull) of 128-cell clusters
after 10,000 MCS (,80 h) as a function of the relative
chemotactic response at cell-cell vs. cell-ECM interfaces. Error
bars show standard deviations over ten simulations.
doi:10.1371/journal.pcbi.1000163.g005
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clusters of 128 cells (256 cells in the Videos). For stronger EC-EC
adhesion, equivalent to positive surface tension, J(c,c),2J(c,M), the
sprouts are longer and thinner and the network less compact than
for zero surface tension. For very weak EC-EC adhesion
J(c,c)&2J(c,M), equivalent to strong negative surface tension, the
ECs separate from each other, so contact-inhibition no longer
occurs, and the clusters do not sprout. For small negative surface
tensions, with values of J(c,c).2J(c,M), chemotaxis overcomes the
negative surface tension, so ECs still touch each other and
sprouting occurs as for zero surface tension, producing thickened
sprouts and elongated clusters. The insets to Figure 7 and Video
S20, S21, S22 show the results for 50#J(c,c)#70.
Figure 6. Cell trajectories of simulated endothelial cells in 128-cell clusters in a contact-inhibited, sprouting cluster (A,B) and in a
non-contact-inhibited, non-sprouting cluster (C,D). (A,C) Cell trajectories during initial sprouting, indicating the cells’ centers of mass at 100
MCS (,50 min) intervals from 100 to 5,000 MCS (,1–40 h). (B,D) Cell trajectories after initial sprouting, indicating the cells’ centers of mass at 1,000
MCS (,8 h) intervals from 4,000 to 20,000 MCS (,30–170 h). Closed circles indicate initial cell positions; open circles indicate final cell positions.
Colors identify individual cells; brightness increases from dark (initial positions) to bright (final positions). Outlines of clusters shown at 1000 MCS
(,8 h) intervals (A,C) or 4000 MCS (,33 h) intervals (B,D). (E) Average displacement of cells from original positions over time in 10 simulations with
128 cells each, in contact-inhibited (solid curves) and non-contact-inhibited simulations (dashed curves). Grey curves indicate standard deviations. (F)
Cell velocity Vi tð Þ~ ~xi tzDtð Þ{~xi t{Dtð Þð Þ=2Dt [19] with Dt= 300 MCS (,2.5 h) for contact-inhibited (solid curves) and non-contact-inhibited
(dashed curves) simulations.
doi:10.1371/journal.pcbi.1000163.g006
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We also investigated how sprouting depends on the chemotactic
strength x(c,M) (Figure 8 and Video S23, S24, S25, S26, S27 S28,
S29, S30, S31, S32, S33). For x(c,M) = 500, most vascular cords
are two cells wide (Video S24), while for For x(c,M).500 the cords
become thinner and longer, with cords only one cell wide (Videos
S25, S26, S27, S28, S29, S30, S31, S32, S33). For higher
chemotactic forces, the cells intercalate, moving to the chemical
gradients’ peak. We have derived the conditions for this folding
instability in our ongoing work (A. Shirinifard and J. A. Glazier,
preprint, 2008). Higher chemotactic strengths increase ruffling of
the cluster boundary, reducing the cluster’s compactness in the
absence of contact inhibition (Figure 8).
We assumed that ECs extend or retract pseudopods depending
on the difference in chemoattractant concentration between the
retracted and extended positions, independent of the absolute
chemoattractant concentrations. However, at higher chemoat-
tractant concentrations, most chemoattractant receptors will
saturate with chemoattractant and become insensitive to chemoat-
tractant levels. To study the effect of saturated chemotactic
response [21] on angiogenic sprouting, we varied the saturation
parameter s (see Eq. 3 in Materials and Methods) leaving all other
parameters unchanged. For s= 0, the chemotactic response is
linear; for s.0, the response to the chemoattractant gradient
vanishes at high concentrations (see Materials and Methods). For
small positive s, the clusters sprout normally (see Figure 9 and
Videos S34, S35, S36); however, for large s, the chemotactic
response weakens at the chemoattractant levels present at the edge
of the cell cluster; thus cells no longer chemotact towards the
cluster’s interior and the sprouting instability disappears (Videos
S37, S38, S39). We could test this prediction experimentally by
partially inactivating the ECs’ chemoattractant receptors. We
observed the same effect when we increased the chemoattractant
secretion rate for moderate response saturation (s= 0.05; see
Figure S2, bottom panel) leading to higher overall chemoattrac-
tant concentrations. We could test this situation experimentally by
overexpressing the chemoattractant in ECs. Since for unsaturated
chemotactic response (s= 0), multiplying the chemoattractant
concentrations is equivalent to multiplying the chemotactic
strength (x(c,M)) by the same factor, increasing the secretion rate
first thins and lengthens the cords by increasing the chemotactic
strength, then eventually prevents sprouting as the chemotactic
response saturates. This effect is most apparent for s= 0.01 (Figure
S2, top panel).
In the Torino Group’s continuum model, the separation
between the cords increases with the diffusion length L of the
chemoattractant, Figure 10 and Videos S40, S41, S42, S43, S44,
S45, S46 show sprouting clusters for a range of diffusion lengths.
In agreement with the Torino Group’s model, longer diffusion
lengths produce thicker cords with larger intercord spaces. The
clusters do not sprout well when L approaches the EC-cluster
diameter. Clusters consisting of 1,024 cells sprout for
D.3?10213 m2 s21 (L.17.3 mm), while 128-cell clusters do not
(Figure 10 and Video S47, S48, S49, S50, S51, S52, S53). If the
diffusion length is shorter than the ECs’ diameter, the clusters
dissociate: the ECs perform random walks with long persistence
Figure 7. Compactness (C=Acluster/Ahull) of 128-cell clusters on
2006200-pixel lattices (,400 mm6400 mm) after 5,000 MCS
(,40 h) for standard chemotaxis, as a function of the adhesion
between endothelial cells, J(c,c). For J(c,c),40 (i.e., J(c,c),2 J(c,M)
the cells adhere without chemotaxis. Insets: Representative configura-
tions after 5000 MCS (,40 h).
doi:10.1371/journal.pcbi.1000163.g007
Figure 8. Compactness (C=Acluster/Ahull) of 128-cell clusters on
2006200-pixel lattices (,400 mm6400 mm ) after 5000 MCS
(,40 h) for standard chemotaxis as a function of absolute
chemotactic strength, x(c,M). Insets: Representative configurations
after 5000 MCS (,40 h).
doi:10.1371/journal.pcbi.1000163.g008
Figure 9. Compactness (C=Acluster/Ahull) of 128-cell clusters on
2006200-lattices (,400 mm6400 mm) after 5000 MCS (,40 h)
for standard chemotaxis as a function of the saturation of the
chemotactic response, s. Insets: representative configurations after
5000 MCS (,40 h).
doi:10.1371/journal.pcbi.1000163.g009
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lengths, moving up the chemoattractant gradients they leave
behind themselves (Video S40 and S47).
A Dissipative Sprouting Mechanism
In our simulations, the trailing edges of the ECs retract actively
in response to the chemoattractant and exert an inward-normal,
compressive force on the EC cluster. To check if sprouting
requires this compressive force, we also simulated a situation in
which only extending pseudopods at cell-ECM interfaces respond to
the chemoattractant, while retraction is chemotactically neutral.
Both sprouting-angiogenesis and vasculogenesis occurred, but
required higher intrinsic cell motilities (larger values of the
parameter T). Figure 11 shows the motilities required under both
assumptions. We looked for sprouting after 5000 MCS (,40 h) in
clusters of 128 cells, each of area <200 mm2, placed in a
400 mm6400 mm lattice, with all other parameters the same as
in Figure 4. For T,100, our original chemotaxis assumptions
produced sprouts, while no sprouting occurred if pseudopods
responded to the chemoattractant only during extension. For
100,T.400, both mechanisms produced sprouts. For T.400,
the ECs broke up into small pieces, a well-characterized, non-
biological artifact of the GGH [35]. With extension-only
chemotaxis, sprouting was slightly slower than for standard,
extension-retraction Savill-Hogeweg [36] chemotaxis, as a plot of
the time evolution of the clusters’ compactness shows (Figure 12
and Video S54, S55, S56). However, at long times (t.2500 MCS)
the compactness of clusters decreased at identical rates for both
methods.
These results suggest an additional mechanism for blood-vessel
sprouting: at the cluster surface, all pseudopod extensions increase
the effective energy slightly, so the chemoattractant inhibits
pseudopod extension. A recent experimental study [43] found
that autocrine secretion of the sprouting inhibitor TGF-b1
enhances branching in mammary epithelial tubes. Our model
suggests a mechanism by which an autocrine, secreted chemical
can act both as a chemoattractant and as an inhibitor. The rates of
pseudopod extensions and retractions are critical to pattern
evolution (Figure 11). Cells in growing tips see a shallower
gradient than do those in valleys between the tips (see, e.g.,
Figure 10. Compactness (C=Acluster/Ahull) of 128-cell clusters
(solid curve) on 2006200-pixel lattices (,400 mm6400 mm) and
1,024-cell clusters (dashed-dotted curve) on 4006400-pixel
lattices (,800 mm6800 mm) after 5000 MCS (,40 h) for Savill-
Hogeweg chemotaxis as a function of the chemoattractant
diffusion constant D. Larger diffusion constants have longer diffusion
lengths, L~
ffiffiffi
D
e
q
. Dashed curve shows the compactness of VE-cadherin-
inhibited 128-cell clusters. Insets: Representative configurations after
5,000 MCS (,40 h) of the 128-cell clusters (left panels) and 1,024-cell
clusters (right panels; not to scale).
doi:10.1371/journal.pcbi.1000163.g010
Figure 11. Compactness (C=Acluster/Ahull) of 128-cell clusters on 4006400-pixel lattices (,400 mm6400 mm) after 5,000 MCS (,40 h)
as a function of the cell motility T, for standard Savill–Hogeweg [36] extension–retraction chemotaxis (solid curve), and for extension-
only chemotaxis (dashed curve). Black curves show the mean over 100 simulations for each T (with a T-increment of 10). Dotted grey curves
indicate one standard deviation. Insets: Representative configurations after 5,000 MCS (,40 h).
doi:10.1371/journal.pcbi.1000163.g011
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Figure 4B), so pseudopod extensions at growing tips are more
frequent than in the valleys between tips because they have a lower
effective-energy cost. During sprouting, conservation of cell area
requires that the cells in the valleys must retract, while those in the
tips protrude. In the Savill-Hogeweg algorithm, retraction is
energetically favorable, while it is energetically neutral in our
pseudopod-extension-only chemotaxis algorithm, making the net
change in effective energy positive with a rate depending on the
cell motility. The effective-energy change is negative in the Savill-
Hogeweg algorithm and thus nearly independent of T (Figure 13,
where H0 is the initial effective energy).
Discussion
We have shown that a single set of cell behaviors, i.e., contact-
inhibited chemotaxis to an autocrine, secreted chemoattractant
can explain aspects of both de novo and sprouting blood-vessel
growth. Our results suggest that branching in aggregates of
chemotacting ECs could result from two separate effects of the
same mechanism. For low cell motilities T, i.e., a low probability
for active, dissipative cellular protrusion, the branching resembles
a buckling instability (see, e.g., [42]), in which the surface cells
exert a surface-normal force on the cluster’s inner core. For larger
cell motilities, the shallower chemoattractant gradients at protru-
sions make the ECs there more likely to extend outward-directed
pseudopods than cells in the valleys between the protrusions.
While we have adopted the Torino Group’s assumption that
ECs chemotax in response to gradients of a diffusible, autocrine,
secreted chemoattractant [12,25], our simulation also reproduces
continuum models that assume that ECs stress the ECM [15],
which either pulls on the surrounding ECs, provides haptotactic
cues for active EC migration [16], or both [26]. Because these
models assume that ECs exert radially-symmetric stresses on the
ECM, the underlying mathematical descriptions of the chemotac-
tic and haptotactic mechanisms are equivalent. In both cases,
contact inhibition should still operate and the patterning
mechanism we have proposed should still apply, with traction or
haptotaxis replacing chemotaxis and the mechanical screening
length replacing the diffusion length. Our simulation may also
apply to the formation of linear structures by non-vascular, glia or
muscle cells cultured on rigid, plastic culture dishes in continu-
ously-shaken medium [17] in which cells explore their environ-
ment using long filopodia, then move towards their neighbors by
pulling themselves along bound filopodia. Thus, the combination
of cell aggregation and contact-inhibition that drives patterning in
our model, could also occur without chemical gradients and even
without ECM.
Figure 12. Evolution of the compactness (C=Acluster/Ahull) of 256-cell clusters on 5006500-pixel lattices (,1,000 mm61,000 mm) vs.
time for standard Savill-Hogeweg [36] extension-retraction chemotaxis (solid and dashed curves, for T=50 and T=200 respectively),
and for extension-only chemotaxis (dash-dotted curve, T = 200), with only extending pseudopods responding to the
chemoattractant. Black curves show the mean of 100 simulations. Dotted grey curves mark one standard deviation. Insets: Representative
configurations after 1000 (,8 h) and 5000 MCS (,40 h). Videos available online.
doi:10.1371/journal.pcbi.1000163.g012
Figure 13. Cumulative energy differences for standard Savill–
Hogeweg [36] extension–retraction chemotaxis (solid and
dashed curves, for T=50 and T=200, respectively), and for
extension-only chemotaxis (dash-dotted curve, T=200) as a
function of time. Black curves show the mean of 100 simulations.
Dotted grey curves mark one standard deviation.
doi:10.1371/journal.pcbi.1000163.g013
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Our simulations also allow us to clarify a number of subtleties
concerning the interpretation of our own and others’ experiments
in which blocking VE-cadherin interfered with normal vascular
patterning. In our in vitro experiments, anti-VE-cadherin
treatment caused ECs to round, in addition to its hypothesized
effect on contact inhibition, so our experiments cannot rule out the
possibility that the anti-VE-cadherin treatment inhibited vascular
patterning because of its effect on EC shape. A further
complication is that anti-VE-cadherin treatment could conceivably
reduce the adhesion between ECs. As we noted above, In VE-
cadherin 2/2 knock-out mice, ECs still form strong adhesive
junctions [18], suggesting that VE-cadherin is not required for
EC-EC binding.
Our simulations show that the contact-inhibition patterning
mechanism operates over a wide range of cell-cell adhesions,
suggesting that changes in adhesivity are not significant provided
that contact-inhibition persists, and independent of cell shape [23],
suggesting that the shape change is not significant. However, we
have also shown that strong cell-cell adhesion plus chemotaxis can
produce vascular-like patterns in simulations [21]. Fortunately, the
three vascular patterning mechanisms (contact-inhibition, cell-
elongation and cell-cell adhesion) have vastly different kinetics
[22]. Thus time-lapse microscopy experiments [19,44] quantifying
the kinetics of capillary-plexus development (see, e.g., [22]), will
allow us to definitively distinguissh among these three patterning
mechanisms. Already, we can say that adhesion-driven patterning
is so slow and requires such strong adhesion that it appears
incompatible with the available qualitative data from experiments.
To further test if VE-cadherin-mediated, contact-dependent
signaling to VEGF-R2 [20], rather than VE-cadherin’s function as
a cell-adhesion molecule is responsible for the effects of anti-VE-
cadherin treatment in mouse yolk sacs, we could experimentally
block signal transduction from VE-cadherin to VEGFR-2,
specifically interfering with VE-cadherin’s signaling function,
while leaving its role as an adhesion molecule intact. A possible
target would be CD148, which phosphorylates VEGFR-2 after
VE-cadherin binding [20,45]. Embryonic vascularization and
angiogenic sprouting are severely deficient in CD148 2/2 knock-
out mice [45], further supporting our hypothesis that VE-
cadherin’s contact-dependent intercellular signaling is crucial to
vasculogenesis and angiogenesis.
Perryn et al. [19] showed that anti-VE-cadherin treatment
reduced sprout extension in murine allantois cultures by 70%,
while it reduced cell-autonomous motility along sprout segments
by 50%. Based on these results, they postulated that VE-cadherin
is required for the motility of ECs along sprouts towards the tip.
However, our simulations show that the observed cell slow-down
after anti-VE-cadherin administration may be an indirect effect of
a reduction of sprouting. Furthermore, our simulations suggest
that even substantially reduced cell motility may not prevent
patterning, though it does slow it down.
In our simulations, branching and pattern formation require
only experimentally-observed cell-level mechanisms, instead of the
blood-vessel-level phenomenology in some other angiogenesis
models [28–30]. However, by starting with a cluster of endothelial
cells, our simulations ignore many events preceding sprout
formation, including the release of plasma proteins by the vessel,
the breakdown of the basal lamina, the detachment of the ECs
from surrounding ECs and smooth muscle cells, and cell
proliferation. They also ignore subsequent processes consolidating
outgrowth of the sprout, including tip-cell selection, any long-
range chemoattractants and chemorepellants that guide the vessel
to its target, the formation of new basal lamina, the sprout’s
association with stabilizing cells including pericytes, lumen
formation within the sprout, and flow-induced remodeling of the
developed vasculature. The mechanism for sprouting and network
formation we have proposed forms a firm basis for future, more
complete models of angiogenesis which include basal lamina and
pericytes. We are currently studying the formation of directed
sprouts with proliferating ECs in response to additional chemoat-
tractants or chemorepellants and analyzing the role of cell
elongation during sprouting. We are also studying the effect of
additional, cell-cell contact-dependent signaling mechanisms,
including delta-notch tip-cell selection [3] and chemoattractant-
response amplifying Eph receptor-ephrin ligand interactions [8].
Materials and Methods
The Glazier–Graner–Hogeweg (GGH) Model
The GGH represents biological cells as patches of identical
lattice indices s ~xð Þ on a square or triangular lattice, where each
index uniquely identifies, or labels a single biological cell.
Connections (links) between neighboring lattice sites of unlike
index s ~xð Þ=s ~x0ð Þ represent bonds between apposing cell
membranes, where the bond energy is J s ~xð Þ,s ~x0ð Þð Þ, assuming that
the types and numbers of adhesive cell-surface proteins determine
J. A penalty increasing with the cell’s deviation from a designated
target volume Atarget(s) imposes a volume constraint on the simulated
ECs. We define the pattern’s effective energy:
H~
X
neighbors
J s ~xð Þ,s ~x0ð Þð Þ 1{d s ~xð Þ,s ~x0ð Þð Þð Þ
zl
X
s
a sð Þ{Atarget sð Þ
 2
,
ð2Þ
where ~x and ~x0 are neighboring lattice sites (up to fourth-order
neighbors), a is the current area of cell s, Atarget(s) is its target area,
l represents a cell’s resistance to compression, and the Kronecker
delta is d(x,y) = {1,x= y; 0,x?y. Each lattice site represents an area
of 2 mm62 mm. Since we assume that ECs do not divide or grow
during patterning, we set Atarget(s) = 50 lattice sites, corresponding
to a cell diameter of about 16 mm, and l= 25 for all cells. The ECs
reside in a very thin layer of extracellular fluid, which is a
generalized cell without a volume constraint and with s= 0. We
assume that the ECs and fluid sit on top of a rigid ECM through
which the chemoattractant diffuses, but we do not represent this
ECM in the GGH lattice. We also assume that the presence of the
fluid does not disturb the chemoattractant distribution in the
ECM. Unless we specify otherwise, we use a bond energy
J(c,c) = 40 between the ECs, and J(c,M) = 20 between the ECs and
the ECM. For these settings the ECs do not adhere without
chemotaxis. We define a special, high cell-border energy J(c,B) = 100
to prevent ECs from adhering to the lattice boundaries. We use
fixed boundary conditions.
To mimic cytoskeletally-driven pseudopod extensions and retrac-
tions, we randomly choose a source lattice site~x, and attempt to copy
its index s ~xð Þ into a randomly-chosen neighboring lattice site~x0. For
better isotropy we select the source site from the twenty, first- to
fourth-nearest neighbors [46]. During a Monte Carlo Step (MCS) we
carry out N copy attempts, with N the number of sites in the lattice. We
set the experimental time per MCS to 30 s; for this setting the
simulated ECs move with nearly their experimental velocity [22]. We
calculate how much the effective energy would change if we
performed the copy, and accept the attempt with probability
P DHð Þ~ e{DHT ,DH§0; 1,DHv0
n o
, where T defines the intrinsic
cell motility. All our simulations, except those in Figures 11–13, use
T= 50.
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In experiments, cells respond to chemoattractant gradients by
executing a more-or-less-strongly biased random walk up or down
the gradient, where, over times short enough to allow us to neglect
adaptation, the velocity of the drift depends on the gradient
strength and the absolute concentration. We therefore define a set
of extensions to the basic GGH model which reproduce these
empirical behaviors due to preferential extension and retraction of
pseudopods up chemoattractant gradients [24] by including a
chemical effective-energy change at each copy attempt [21,36],
DHchemotaxis~{m
c ~x0ð Þ
1zsc ~x0ð Þ{
c ~xð Þ
1zsc ~xð Þ
 
, ð3Þ
where c is the concentration of the chemoattractant, which we
assume is present everywhere in a layer of ECM under the ECs, ~x0
is the target site, ~x the source site, and s regulates the saturation of
the chemotactic response. Unless we specify otherwise, we set
s= 0, in which case chemotaxis depends linearly on the
chemoattractant gradient only, independent of the chemoattrac-
tant concentration. DHchemotaxis R 0 for large values of s and, for
s?0, for high chemical concentrations. The chemotaxis coefficient is
m= x(c,M) at cell-ECM interfaces and m= x(c,c) at cell-cell
interfaces respectively. Setting x(c,c) = 0 x(c,M) = 500 ensures that
chemotactic extensions occur only at cell-ECM interfaces,
reflecting VE-cadherin’s suppression of pseudopods. Both extend-
ing and retracting pseudopods contribute to the chemical effective-
energy change. To implement pseudopod-extension-only chemotaxis (see
Figures 11–13), where only extending pseudopods at the cell-ECM
interface respond to the chemoattractant, cells experience a
chemical effective-energy change only if the source lattice site ~x
belongs to an EC, i.e.,
DHchemotaxis~{ 1{d s ~xð Þ,0ð Þð Þm c ~x
0ð Þ
1zsc ~x0ð Þ{
c ~xð Þ
1zsc ~xð Þ
 
: ð4Þ
For a more detailed discussion of chemotaxis in the GGH model
see [47]. We solve the partial-differential equation for chemoat-
tractant diffusion and degradation (Eq. 1) numerically using a
finite-difference scheme on a lattice matching the GGH lattice.
We use 15 diffusion steps per MCS, with Dt= 2 s. For these
parameters, the chemoattractant diffuses more rapidly than the
ECs, enabling us to ignore advection in the medium as the cells
push the fluid.
Source code and parameters for the simulations in this paper
are available online in Protocol S1 from the supporting material,
and from http://sourceforge.net/projects/tst. Parameter files for
the simulations in this paper are included in Dataset S1.
Allantois Culture and Immunolabeling
We dissected allantoides from mouse embryos at embryonic
stages 7.5–8.0. We washed the explants in fresh, cold ePBS and
pipetted them into fibronectin-coated (5 mg/ml) Delta-T culture
dishes (Bioptechs, Butler, PA) containing high-glucose, phenol-red-
free Dulbecco’s modified Eagles’ medium (DMEM) supplemented
with 10% fetal bovine serum (FBS), 1% penicillin-streptomycin,
and 1% L-glutamine (GibcoBRL, Grand Island, NY). We
maintained the allantoic explants using standard culture condi-
tions (37uC and 5% CO2/95% air atmosphere) in a custom-
designed culture chamber for 12–24 hours in the presence of an
endothelial-specific marker, CD34 monoclonal antibody (BD
PharMingen, San Diego, CA) directly conjugated to Cy3
(Amersham Biosciences). We fixed the allantoides in 3%
paraformaldehyde for 20 minutes at room temperature, followed
by an ePBS wash. For VE-cadherin antibody perturbations, we
added anti-VE-cadherin monoclonal antibody (BD PharMingen,
San Diego, CA) at 25 mg/ml to the culture medium.
Image Acquisition
We observed the cultures with a 106objective (0.30 N.A.) on an
inverted, automated, wide-field, epifluorescence/differential-inter-
ference-contrast (DIC) microscope (Leica DMIRE2, Leica Micro-
systems, Germany). We recorded images (6086512 pixel spatial
and 12-bit intensity resolution) with a cooled Retiga 1300 camera
(QImaging, Burnaby, British Columbia) in 262 binned acquisition
mode, using 100–300 ms exposures. Image acquisition and
microscope settings used software described in [44].
Supporting Information
Dataset S1 Parameter files for the simulations shown in
Figures 2, 4, 11, and 12, packed as a tar.gz archive To use,
unpack the parameter-file archive and install the Tissue Simula-
tion Toolkit (Protocol S1). Run the simulations from the command
line using the command ‘‘vessel [parameter-file]’’. Reproduce the
other simulations by editing the parameter files using a standard
text editor to set the values specified in the text.
Found at: doi:10.1371/journal.pcbi.1000163.s001 (4 KB ZIP)
Protocol S1 Tissue Simulation Toolkit v0.1.3. The source code
for the software used for the simulations presented in this paper is
also available from http://sourceforge.net/projects/tst. Installa-
tion: Unpack and compile according to the instructions given in
the INSTALL file The code is written in C++ using the cross-
platform (Windows, Mac, or Unix/Linux) library Qt (available
from www.trolltech.com).
Found at: doi:10.1371/journal.pcbi.1000163.s002 (332 KB ZIP)
Figure S1 Compactness (C=Acluster/Ahull) of 128-cell clusters
after 5000 MCS (,40 h) as a function of the cell length, in the
presence (solid curve) or absence (dashed curve) of contact
inhibition. Lengths given in terms of the target length L as defined
in Merks et al. 2006 [22]. Grey curves show standard deviations
over ten simulations.
Found at: doi:10.1371/journal.pcbi.1000163.s003 (1278 KB EPS)
Figure S2 Configurations of 128-cell clusters after 5,000 MCS
(,40 h) for increasing chemoattractant secretion rates for low
(s= 0.01) and high (s= 0.05) chemoattractant receptor saturations.
Found at: doi:10.1371/journal.pcbi.1000163.s004 (3536 KB EPS)
Video S1 Endothelial cell aggregation without contact-inhibited
chemotaxis. Simulation initiated with 1,000 scattered cells. 0 MCS
to 20,000 MCS (,0–170 h), 100 MCS per frame.
Found at: doi:10.1371/journal.pcbi.1000163.s005 (1902 KB AVI)
Video S2 Endothelial cell aggregation in with contact-inhibited
chemotaxis. Simulation initiated with 1000 scattered cells. 0 MCS
to 2000 MCS (,0–20 h), 10 MCS per frame.
Found at: doi:10.1371/journal.pcbi.1000163.s006 (4534 KB AVI)
Video S3 Same simulation as Video S2. 0 MCS to 20,000 MCS
(,0–170 h), 100 MCS per frame.
Found at: doi:10.1371/journal.pcbi.1000163.s007 (2000 KB AVI)
Video S4 Sprouting instability in a simulation with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 2,000 MCS (,0–20 h), 10 MCS per frame.
Found at: doi:10.1371/journal.pcbi.1000163.s008 (4554 KB AVI)
Video S5 Same simulation as Video S4. 0 MCS to 20,000 MCS
(,0–170 h), 100 MCS per frame.
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Found at: doi:10.1371/journal.pcbi.1000163.s009 (1895 KB AVI)
Video S6 Simulation with non-contact–inhibited chemotaxis,
initiated with a cluster of 256 endothelial cells. 0 MCS to 2,000
MCS (,0–20 h), 10 MCS per frame.
Found at: doi:10.1371/journal.pcbi.1000163.s010 (1640 KB AVI)
Video S7 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 5.
Found at: doi:10.1371/journal.pcbi.1000163.s011 (699 KB AVI)
Video S8 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 10.
Found at: doi:10.1371/journal.pcbi.1000163.s012 (685 KB AVI)
Video S9 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 15.
Found at: doi:10.1371/journal.pcbi.1000163.s013 (691 KB AVI)
Video S10 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 20.
Found at: doi:10.1371/journal.pcbi.1000163.s014 (669 KB AVI)
Video S11 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 25.
Found at: doi:10.1371/journal.pcbi.1000163.s015 (677 KB AVI)
Video S12 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 30.
Found at: doi:10.1371/journal.pcbi.1000163.s016 (669 KB AVI)
Video S13 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 35.
Found at: doi:10.1371/journal.pcbi.1000163.s017 (679 KB AVI)
Video S14 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 40.
Found at: doi:10.1371/journal.pcbi.1000163.s018 (648 KB AVI)
Video S15 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 45.
Found at: doi:10.1371/journal.pcbi.1000163.s019 (383 KB AVI)
Video S16 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 50.
Found at: doi:10.1371/journal.pcbi.1000163.s020 (557 KB AVI)
Video S17 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 55.
Found at: doi:10.1371/journal.pcbi.1000163.s021 (528 KB AVI)
Video S18 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 60.
Found at: doi:10.1371/journal.pcbi.1000163.s022 (516 KB AVI)
Video S19 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 65.
Found at: doi:10.1371/journal.pcbi.1000163.s023 (457 KB AVI)
Video S20 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 70.
Found at: doi:10.1371/journal.pcbi.1000163.s024 (439 KB AVI)
Video S21 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 75.
Found at: doi:10.1371/journal.pcbi.1000163.s025 (411KB AVI)
Video S22 Effect of cell adhesion on the proposed sprouting-
angiogenesis mechanism (cf. Figure 7). Simulations with contact-
inhibited chemotaxis, initiated with a cluster of 256 endothelial
cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS per frame.
J(c,c) = 80.
Found at: doi:10.1371/journal.pcbi.1000163.s026 (383 KB AVI)
Video S23 Effect of the chemotactic strength on the proposed
sprouting-angiogenesis mechanism (cf. Figure 8). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. x(c,M) = 0.
Found at: doi:10.1371/journal.pcbi.1000163.s027 (238 KB AVI)
Video S24 Effect of the chemotactic strength on the proposed
sprouting-angiogenesis mechanism (cf. Figure 8). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. x(c,M) = 500.
Found at: doi:10.1371/journal.pcbi.1000163.s028 (653 KB AVI)
Video S25 Effect of the chemotactic strength on the proposed
sprouting-angiogenesis mechanism (cf. Figure 8). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. x(c,M) = 1,000.
Found at: doi:10.1371/journal.pcbi.1000163.s029 (707 KB AVI)
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Video S26 Effect of the chemotactic strength on the proposed
sprouting-angiogenesis mechanism (cf. Figure 8). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. x(c,M) = 1,500.
Found at: doi:10.1371/journal.pcbi.1000163.s030 (714 KB AVI)
Video S27 Effect of the chemotactic strength on the proposed
sprouting-angiogenesis mechanism (cf. Figure 8). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. x(c,M) = 2,000.
Found at: doi:10.1371/journal.pcbi.1000163.s031 (727 KB AVI)
Video S28 Effect of the chemotactic strength on the proposed
sprouting-angiogenesis mechanism (cf. Figure 8). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. x(c,M) = 2,500.
Found at: doi:10.1371/journal.pcbi.1000163.s032 (765 KB AVI)
Video S29 Effect of the chemotactic strength on the proposed
sprouting-angiogenesis mechanism (cf. Figure 8). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. x(c,M) = 3,000.
Found at: doi:10.1371/journal.pcbi.1000163.s033 (797 KB AVI)
Video S30 Effect of the chemotactic strength on the proposed
sprouting-angiogenesis mechanism (cf. Figure 8). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. x(c,M) = 3,500.
Found at: doi:10.1371/journal.pcbi.1000163.s034 (805 KB AVI)
Video S31 Effect of the chemotactic strength on the proposed
sprouting-angiogenesis mechanism (cf. Figure 8). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. x(c,M) = 4,000.
Found at: doi:10.1371/journal.pcbi.1000163.s035 (835 KB AVI)
Video S32 Effect of the chemotactic strength on the proposed
sprouting-angiogenesis mechanism (cf. Figure 8). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. x(c,M) = 4,500.
Found at: doi:10.1371/journal.pcbi.1000163.s036 (853 KB AVI)
Video S33 Effect of the chemotactic strength on the proposed
sprouting-angiogenesis mechanism (cf. Figure 8). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. x(c,M) = 5,000.
Found at: doi:10.1371/journal.pcbi.1000163.s037 (858 KB AVI)
Video S34 Effect of chemotaxis saturation on the proposed
sprouting-angiogenesis mechanism (cf. Figure 9). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. s= 0.0.
Found at: doi:10.1371/journal.pcbi.1000163.s038 (655 KB AVI)
Video S35 Effect of chemotaxis saturation on the proposed
sprouting-angiogenesis mechanism (cf. Figure 9). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. s= 0.05.
Found at: doi:10.1371/journal.pcbi.1000163.s039 (577 KB AVI)
Video S36 Effect of chemotaxis saturation on the proposed
sprouting-angiogenesis mechanism (cf. Figure 9). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. s= 0.1.
Found at: doi:10.1371/journal.pcbi.1000163.s040 (409 KB AVI)
Video S37 Effect of chemotaxis saturation on the proposed
sprouting-angiogenesis mechanism (cf. Figure 9). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. s= 0.15.
Found at: doi:10.1371/journal.pcbi.1000163.s041 (224 KB AVI)
Video S38 Effect of chemotaxis saturation on the proposed
sprouting-angiogenesis mechanism (cf. Figure 39). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. s= 0.2.
Found at: doi:10.1371/journal.pcbi.1000163.s042 (213 KB AVI)
Video S39 Effect of chemotaxis saturation on the proposed
sprouting-angiogenesis mechanism (cf. Figure 9). Simulations with
contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. s= 0.25.
Found at: doi:10.1371/journal.pcbi.1000163.s043 (215 KB AVI)
Video S40 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. D= 4?10214 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s044 (1053 KB AVI)
Video S41 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. D= 5?10214 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s045 (717 KB AVI)
Video S42 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. D= 1?10213 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s046 (631 KB AVI)
Video S43 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. D= 2?10213 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s047 (501 KB AVI)
Video S44 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. D= 3?10213 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s048 (418 KB AVI)
Video S45 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. D= 4?10213 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s049 (371 KB AVI)
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Video S46 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 256
endothelial cells. 0 MCS to 20,000 MCS (,0–170 h), 100 MCS
per frame. D= 5?10213 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s050 (316KB AVI)
Video S47 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 1024
endothelial cells. MCS 0 to 20,000 (,0–170 h), 100 MCS per
frame. D= 1?10214 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s051 (1376 KB AVI)
Video S48 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 1024
endothelial cells. MCS 0 to 20,000 (,0–170 h), 100 MCS per
frame. D= 5?10214 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s052 (1011 KB AVI)
Video S49 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 1024
endothelial cells. MCS 0 to 20,000 (,0–170 h), 100 MCS per
frame. D= 1?10213 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s053 (1003 KB AVI)
Video S50 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 1024
endothelial cells. MCS 0 to 20,000 (,0–170 h), 100 MCS per
frame. D= 2?10213 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s054 (994 KB AVI)
Video S51 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 1024
endothelial cells. MCS 0 to 20,000 (,0–170 h), 100 MCS per
frame. D= 3?10213 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s055 (976 KB AVI)
Video S52 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 1024
endothelial cells. MCS 0 to 20,000 (,0–170 h), 100 MCS per
frame. D= 4?10213 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s056 (978 KB AVI)
Video S53 Effect of the diffusion constant D on the proposed
sprouting-angiogenesis mechanism (cf. Figure 10). Simulations
with contact-inhibited chemotaxis, initiated with a cluster of 1024
endothelial cells. MCS 0 to 20,000 (,0–170 h), 100 MCS per
frame. D= 5?10213 m2 s21.
Found at: doi:10.1371/journal.pcbi.1000163.s057 (982 KB AVI)
Video S54 Sprouting of a 256-cell cluster on a 5006500-pixel
lattice (,1 mm61 mm) with standard Savill–Hogeweg, extension-
retraction chemotaxis at T= 50, as in Figure 12.
Found at: doi:10.1371/journal.pcbi.1000163.s058 (2366 KB AVI)
Video S55 Sprouting of a 256-cell cluster on a 5006500-pixel
lattice (,1 mm61 mm) with standard Savill–Hogeweg, exten-
sion–retraction chemotaxis at T= 200, as in Figure 12.
Found at: doi:10.1371/journal.pcbi.1000163.s059 (2372 KB AVI)
Video S56 Sprouting of a 256-cell cluster on a 5006500-pixel
lattice (,1 mm61 mm) with extension-only chemotaxis at
T= 200, as in Figure 12.
Found at: doi:10.1371/journal.pcbi.1000163.s060 (2381 KB AVI)
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